NASDAQ:MRKR
Marker Therapeutics, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.markertherapeutics.comipo date
Jul 16, 2002
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-speci...Show More
Earnings
Earnings Release in 16 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus